Rossix.blue.jpg
Home Products About Us Contact

Chromogenic Kits

Learn more about our Chromogenic Kits.

Phospholipid Emulsions

Our highly stable phospholipid emulsions are suitable for use in analyses related to procoagulant and anticoagulant pathways.

References

.

Rossix is a company devoted to Thrombosis and Hemostasis. The company represents the experience of more than 30 years of development work in the field. 

 

Rossix provides Products for use in Hemostasis Research and Quality Control. The vast majority of our customers are pharmaceutical companies and academic bioscience laboratories.

Rox Factor XIa

REF 110050

A chromogenic kit for quantitative activity determination of Factor XIa in enriched or highly purified protein preparations.

Use together with Factor XIa Calibrator and Control assigned in U/ml against the first NIBSC reference reagent, 11/236.

ISTH - Melbourne July 6-10

Rossix will present  three posters related to analysis of Factor IX at the ISTH in Melbourne.

Take the oportunity to meet us there! Contact us at info@rossix.com or drop by during the poster sessions.

Rox Factor IX - CE

REF 900020

Our chromogenic kit for quantitative activity determination of Factor IX is CE marked and 

approved for In Vitro Diagnostic Use in Europe.

Outside Europe the Rox Factor IX kit is available for research use.

Where to Buy?

In a number of countries, Rossix has local distributors which are specialized in the field of Thrombosis and Hemostasis.

For other countries Rossix sells directly to end users:

News

2019-06-20 ISTH, Melbourne July 6-10, 2019.

Rossix will present three posters related to analysis of Factor IX at the ISTH in Melbourne:

PB0099 - Evaluation of Lupus Anticoagulant interference in a chromogenic Factor IX kit for determination of

Factor IX activity

PB1294 - Assessment of Factor IX Padua activity with a one-stage clotting method and with FXIa- and tissue factor/FVIIa-based chromogenic methods

PB1295 - Recombinant Factor IX fused with albumin (rFIX-HSA) is underassigned by one-stage methods with silica as contact activator

More information

  

2016-06-22 Publication in collaboration with NovoNordisk

Rosén P, Rosén S, Ezban M, Persson E.

Overestimation of N-glycoPEGylated factor IX activity in one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX.

J Thromb Haemost 2016; 14: 1420-7.

  

2015-04-13 Publication in collaboration with AstraZeneca

Ann Lövgren et al. Blood Coagulation and Fibrinolysis, Characterization of thrombin derived from 

human recombinant prothrombin.

Open access: click here

  

Search